Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 5205-5210, November 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamblin, M. R.
Right arrow Articles by Hasan, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamblin, M. R.
Right arrow Articles by Hasan, T.

Effect of Charge on the Interaction of Site-specific Photoimmunoconjugates with Human Ovarian Cancer Cells1

Michael R. Hamblin, Jaimie L. Miller and Tayyaba Hasan2

Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, WEL224, Harvard Medical School, Boston, Massachusetts 02114

A marked effect of charge modification on the uptake and phototoxicity of a photoimmunoconjugate (PIC) was demonstrated. A site-specific conjugation strategy was developed to attach the photosensitizer chlorine6 (ce6) to the F(ab')2 fragment of the murine antiovarian cancer monoclonal antibody OC125. Poly-L-lysine linkers carrying ce6 with a cationic charge or by polysuccinylation with an anionic charge were used and covalently attached to partially reduced antibody via a heterobifunctional reagent. PICs were purified by column chromatography and were also radiolabeled with 125I. PIC binding and uptake were studied with a human ovarian cancer cell line, NIH-OVCAR-5, and a nonantigen-expressing colon cancer cell line, SW1116, and the data were compared with the binding and uptake of nonspecific rabbit IgG PICs. PICs with both cationic and anionic charges preserved antigen binding as shown by competition studies with native antibody, but the cationic PIC had up to 17 times higher cellular uptake of ce6, probably due to enhanced internalization. The ratio of ce6 to 125I retained by the cells varied with the likelihood of internalization and lysosomal degradation. The phototoxicity of the PICs generally varied with their uptake, but a correlation was found between lysosomal hydrolysis as measured by an increased cellular ratio of ce6:125I and increased relative phototoxicity. These data suggest cationic PICs may have advantages for photoimmunotherapy of disseminated intracavity cancer following local administration.

1 This work was supported by NIH Grant RO1 AR40352 and in part by the Department of Defense Free Electron Laser Program facilities.

2 To whom requests for reprints should be addressed. Phone: (617) 726-6996; Fax: (617) 726-3192.

Received 5/ 8/96. Accepted 9/16/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin, and T. Hasan
Pegylation of a Chlorine6 Polymer Conjugate Increases Tumor Targeting of Photosensitizer
Cancer Res., October 1, 2001; 61(19): 7155 - 7162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Soukos, M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch, and T. Hasan
Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer in Vivo
Cancer Res., June 1, 2001; 61(11): 4490 - 4496.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Marco Del Governatore, M. R. Hamblin, C. R. Shea, I. Rizvi, K. G. Molpus, K. K. Tanabe, and T. Hasan
Experimental Photoimmunotherapy of Hepatic Metastases of Colorectal Cancer with a 17.1A Chlorine6 Immunoconjugate
Cancer Res., August 1, 2000; 60(15): 4200 - 4205.
[Abstract] [Full Text]


Home page
IOVSHome page
J. Khadem, A. A. Veloso Jr, F. Tolentino, T. Hasan, and M. R. Hamblin
Photodynamic Tissue Adhesion with Chlorine6 Protein Conjugates
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3132 - 3137.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. R. Duska, M. R. Hamblin, J. L. Miller, and T. Hasan
Combination Photoimmunotherapy and Cisplatin: Effects on Human Ovarian Cancer Ex Vivo
J Natl Cancer Inst, September 15, 1999; 91(18): 1557 - 1563.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.